How to Stratify Postpartum Depression Risk in Pregnant Patients With Depression History
How should clinicians identify which pregnant patients with a recent history of depressive episodes are at highest risk for postpartum depression?
Pregnant patients with a recent depressive episode history have a high baseline risk of postpartum depression, and in this cohort more than one-third had postpartum depression within a year after delivery. Clinicians need a practical way to identify which patients warrant closer monitoring, earlier care connection, and more focused preventive attention during pregnancy and the postpartum year.
-
Confirm that the patient fits the high-risk population studied
Apply this workflow to adult patients with a live birth who have a recent history of depression before pregnancy. In the study, this meant a depression or postpartum depression ICD-9 or ICD-10 diagnosis in the year before the last menstrual period plus at least 1 filled antidepressant medication at an adequate dose in the 6 months before the last menstrual period.
-
Screen for prior postpartum depression
Determine whether the patient had postpartum depression documented in the year before the last menstrual period using the problem list or visit diagnoses. Compared with patients who had depression history without prior postpartum depression, those with a prior postpartum depression history had higher adjusted risk of postpartum depression overall, with an adjusted risk ratio of 1.31.
-
Assess early pregnancy depressive symptoms with the first PHQ-9
Use the first documented PHQ-9 score after the last menstrual period to classify symptom severity early in pregnancy. Compared with PHQ-9 less than 5, risk was higher even with mild symptoms at 5 to 9, with increasing risk across moderate 10 to 14 and moderate-severe 15 to 19 ranges; moderate-severe symptoms carried an adjusted risk ratio of 1.92 for overall postpartum depression and 3.58 for severe postpartum depression.
-
Review prepregnancy antidepressant dose intensity
Identify whether the patient required a higher antidepressant dose range before the last menstrual period. Higher dosing before pregnancy was associated with higher adjusted risk of postpartum depression overall, with an adjusted risk ratio of 1.15, and of severe postpartum depression, with an adjusted risk ratio of 1.34.
-
Incorporate demographic and socioeconomic risk markers
Recognize that compared with White patients, patients identifying as Black, Asian/Pacific Islander, and LatinX had higher adjusted postpartum depression risk in this cohort. Lower median neighborhood income, defined as 60,000 to 120,000 dollars or less than 60,000 dollars versus more than 120,000 dollars, and Medicaid insurance were also associated with higher risk.
-
Use parity as a modifier rather than an alarm feature
Account for parity when estimating risk. Compared with nulliparous patients, parity of 1 and parity of 2 or more were each associated with a lower adjusted risk ratio of 0.90, while multiple gestation was not associated with higher postpartum depression risk.
-
Prioritize enhanced surveillance for patients with multiple risk markers
Treat combinations of prior postpartum depression, higher prenatal PHQ-9 symptom burden, higher prepregnancy antidepressant dosing, antidepressant discontinuation during pregnancy, and socioeconomic or racial and ethnic disadvantage as signals for closer follow-up. The authors conclude that these factors can inform personalized screening, focused preventive efforts, and earlier connection to depression care during pregnancy and the postpartum year.
Clinical Considerations
- This workflow is drawn from a retrospective EHR study and identifies factors associated with postpartum depression risk rather than a validated point-based prediction rule.
- The cohort was limited to insured patients in an integrated system with universal perinatal PHQ-9 screening, so applicability may be limited in settings with different access to care.
- The study cohort required both a recent depression-related diagnosis and adequate antidepressant use before pregnancy, which may limit generalizability to patients treated with lower doses or not taking antidepressants.
- Psychosocial stressors such as social support, intimate partner violence, and other pregnancy-related stressors were not captured and therefore are not included in this workflow.
Bottom Line
In pregnant patients with recent depressive episodes, prior postpartum depression and early antenatal depressive symptoms are the strongest practical markers to flag for intensified postpartum depression surveillance, with additional risk from antidepressant discontinuation, higher prepregnancy dose requirements, and socioeconomic and racial or ethnic disadvantage.
